Alpha-glucosidase Inhibitors Market Size

Alpha-glucosidase Inhibitors Market size is estimated at USD 3.4 billion in 2024 and is predicted to exceed USD 5.4 billion by the end of 2037, growing at over 3.7% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of alpha-glucosidase inhibitors is assessed at USD 3.5 billion.

One of the major factors boosting the alpha-glucosidase inhibitors market is the increasing prevalence of diabetes across the world. For instance, according to a 2023 published report by the Institute for Health Metrics and Evaluation (IHME), , states that more than half a billion people are living with diabetes around the globe. The worldwide prevalence rate of diabetes is 6.1%, whereas North America and the Middle East hold 9.3% and is predicted to reach 16.8% by 2050. Furthermore, based on demographics, people 65 and older age are capturing more than 20% of the diabetes prevalence rate. The rising risk of diabetes drives demand for effective glucose management therapies and is generating profitable opportunities for anti-diabetic drug producers. Moreover, the key market players are investing heavily in research and development activities to introduce advanced and effective solutions such as alpha-glucosidase inhibitors.